RESUMO
INTRODUCTION: Percutaneous endoscopic gastrostomy (PEG) is considered a safe and effective method for nutritional support in patients with malnutrition and swallowing impairment with an estimated survival of over two months. Some indications, such as advanced cognitive decline, contraindicate the technique. MATERIALS AND METHODS: All patients who underwent PEG placement between January 2001 and May 2019 were included. Clinical data, indication, complications, and mortality were retrospectively analyzed. RESULTS: A total of 648 patients (46.5% male, mean age 70±18.5 years) were included. The most common indications for PEG were advanced cognitive decline (31.5%) and cerebrovascular disease (18.8%). The mean follow-up was 12.07 months (IQR 3.27-34.73). 39.5% of patients experienced complications (systemic 17.9%, local 28.5%). The most frequent were bronchoaspiration (9.7%) and rupture/dysfunction (13.9%), respectively. The presence of early complications (HR 1.63 [1.20-2.21]) and age (HR 1.02 [1.01-1.02]) were associated with shorter survival time, while female sex was a protective factor (HR 0.78 [0.66-0.94]). CONCLUSIONS: PEG is not without complications, with 39.5% of patients experiencing them. Patients with advanced dementia, male sex, older age, and systemic complications have lower survival following PEG placement.
RESUMO
We present the case of a 38-year-old man with no previous medical history who went to the emergency department due to abdominal pain and diarrheal stools with blood of 24 hours of evolution. The patient reports consumption of anti-inflammatories the previous days due to back pain.
Assuntos
Colite Isquêmica , Colite , Dor Abdominal/induzido quimicamente , Adulto , Anti-Inflamatórios não Esteroides/efeitos adversos , Colite/induzido quimicamente , Colite Isquêmica/induzido quimicamente , Colite Isquêmica/diagnóstico por imagem , Diarreia/induzido quimicamente , Humanos , MasculinoRESUMO
No disponible
Assuntos
Humanos , Masculino , Adulto , Hemorragia Gastrointestinal/induzido quimicamente , Inibidores Seletivos de Recaptação de Serotonina/administração & dosagem , Anti-Inflamatórios não Esteroides/administração & dosagem , Gastroscopia/métodos , Úlcera Duodenal/diagnóstico por imagem , Hemorragia Gastrointestinal/complicações , Inibidores Seletivos de Recaptação de Serotonina/efeitos adversos , Anti-Inflamatórios não Esteroides/efeitos adversos , Dor Abdominal/etiologia , Úlcera Duodenal/cirurgia , Biópsia , Enteroscopia de Balão Único/métodos , Fatores de RiscoRESUMO
No disponible
Assuntos
Humanos , Masculino , Adulto , Doença de Crohn/diagnóstico , Enteropatias Parasitárias/diagnóstico , Abscesso Hepático Amebiano/diagnóstico , Antiprotozoários/uso terapêutico , Colonoscopia , Doença de Crohn/tratamento farmacológico , Diagnóstico Diferencial , Erros de Diagnóstico , Drenagem/métodos , Entamoeba/isolamento & purificação , Doenças Inflamatórias Intestinais/diagnóstico , Enteropatias Parasitárias/terapia , Abscesso Hepático Amebiano/terapia , Metronidazol/uso terapêutico , Ultrassonografia de IntervençãoRESUMO
No disponible